Explore
Validate
LearnH00057492-M02
antibody from Novus Biologicals
Targeting: ARID1B
6A3-5, BAF250b, DAN15, ELD/OSA1, KIAA1235, p250R
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- H00057492-M02 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#H00057492-M02, RRID:AB_920642
- Product name
- Mouse Monoclonal ARID1B Antibody
- Antibody type
- Monoclonal
- Description
- IgG purified. ARID1B (2F2)
- Reactivity
- Human, Mouse
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 0.1 mg
- Storage
- Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Submitted references Arid1b haploinsufficiency disrupts cortical interneuron development and mouse behavior.
ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines.
Transmembrane receptor CXCR7 increases the risk of extrahepatic metastasis of relatively well-differentiated hepatocellular carcinoma through upregulation of osteopontin.
Dynamics of expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle.
Jung EM, Moffat JJ, Liu J, Dravid SM, Gurumurthy CB, Kim WY
Nature neuroscience 2017 Dec;20(12):1694-1707
Nature neuroscience 2017 Dec;20(12):1694-1707
ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines.
Khursheed M, Kolla JN, Kotapalli V, Gupta N, Gowrishankar S, Uppin SG, Sastry RA, Koganti S, Sundaram C, Pollack JR, Bashyam MD
British journal of cancer 2013 May 28;108(10):2056-62
British journal of cancer 2013 May 28;108(10):2056-62
Transmembrane receptor CXCR7 increases the risk of extrahepatic metastasis of relatively well-differentiated hepatocellular carcinoma through upregulation of osteopontin.
Xue TC, Chen RX, Ren ZG, Zou JH, Tang ZY, Ye SL
Oncology reports 2013 Jul;30(1):105-10
Oncology reports 2013 Jul;30(1):105-10
Dynamics of expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle.
Flores-Alcantar A, Gonzalez-Sandoval A, Escalante-Alcalde D, Lomelí H
Cell and tissue research 2011 Jul;345(1):137-48
Cell and tissue research 2011 Jul;345(1):137-48
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: ARID1B Antibody (2F2) [H00057492-M02] - ARID1B monoclonal antibody (M02), clone 2F2 Analysis of ARID1B expression in Hela S3 NE.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunocytochemistry/Immunofluorescence: ARID1B Antibody (2F2) [H00057492-M02] - Analysis of monoclonal antibody to ARID1B on HeLa cell. Antibody concentration 10 ug/ml.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: ARID1B Antibody (2F2) [H00057492-M02] - IHC analysis of ARID1B in human pancreatic cancer tissue samples. Image courtesy of anonymous customer product review.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: ARID1B Antibody (2F2) [H00057492-M02] - Analysis of monoclonal antibody to ARID1B on formalin-fixed paraffin-embedded human placenta. Antibody concentration 3 ug/ml.
